Form 4: Humana Director Kurt J. Hilzinger Reports Acquisition of Stock Units

Director Kurt J. Hilzinger reports the acquisition of additional Humana stock units through deferred fees and dividend reinvestments.

Summary

• Kurt J. Hilzinger, a director at Humana Inc., filed a Form 4 disclosing changes in his beneficial ownership.
• The report details the acquisition of 345 restricted stock units on March 31, 2025, at a price of $263.875 per unit.
• These units were acquired through the election to convert director's cash fees into stock units.
• Hilzinger also holds 24,034 restricted stock units from annual director's fees and 2,753 restricted stock units from reinvested dividends.
• These stock units are deferred until his resignation as a director, at which point they will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Following the reported transaction, Hilzinger beneficially owns 19,448 shares of Humana common stock directly and 14,645 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock unit acquisition, which doesn't inherently indicate positive or negative sentiment.

Positives

• The director's decision to convert cash fees into stock units could be interpreted as a sign of confidence in the company's future performance.

Future Outlook

The acquired stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon the director's resignation.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company.

Comparison to Industry Standards

• Director compensation in the form of stock and stock units is a common practice among publicly traded companies, aligning the interests of directors with those of shareholders.
• Deferred stock unit plans are also common, allowing directors to defer income and potentially benefit from future stock appreciation.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency into director compensation and alignment with shareholder interests.

Key Dates

Keywords

Form 4, Humana, Director, Stock Units, Beneficial Ownership, Hilzinger, Deferred Compensation